metricas
covid
Buscar en
Vacunas (English Edition)
Toda la web
Inicio Vacunas (English Edition) Study of Meningitis B vaccination schedule on the childhood in Zaragoza
Journal Information
Vol. 23. Issue 3.
Pages 159-164 (September - December 2022)
Share
Share
Download PDF
More article options
Vol. 23. Issue 3.
Pages 159-164 (September - December 2022)
Original article
Study of Meningitis B vaccination schedule on the childhood in Zaragoza
Estudio sobre la pauta vacunal infantil de meningitis B en Zaragoza
Cristina Genzor Ríosa,
Corresponding author
cgenzor@salud.aragon.es

Corresponding author.
, María Vázquez Sánzcheza, David Molina Herranza, María Violeta Fariña Jaraa, Mónica López Camposb, Enrique Llamas Agundezc, María Pilar Viñas Viamonteb, Carlos Fernández Lozanod
a Hospital Universitario Miguel Servet, Zaragoza, Spain
b Centro de Salud Actur Norte, Zaragoza, Spain
c Sector I, Zaragoza, Spain
d Hospital General de la Defensa, Zaragoza, Spain
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (2)
Abstract
Background

Meningococcal disease caused by Neisseria meningitidis is a life-threatening disease, with the highest incidence rates in children under 5 years of age. Since 2015, a vaccine against serogroup B, the most prevalent in Europe, has been available in Spain. The objective of the study was to analyse the vaccination of children with Meningitis B in Zaragoza.

Methods

A descriptive observational study was carried out with 11 776 of 13 Health Centres of Sector I of Zaragoza, aged 0 months to 15 years, with a history of Meningitis B vaccination between January 2015 and December 2019. It was determined sex, date of birth, date and age of primary vaccination, health centre, and vaccination schedule. A descriptive analysis and hypothesis testing was carried out to analyse the results.

Results

50.4% of those vaccinated were between 2 and 9 years old. In 2016, children under 3 months of age represented 7.2% of the total vaccinated, increasing in 2019 to 50.9%. 83.8% of the children were well vaccinated, with a mean age of 5.5 years. Interval errors were more common in the 12–23-month group (55.9%). There were no differences between both sexes in relation to the pattern received.

Conclusions

The percentage of well vaccinated is high. The percentage of interval errors in the 12–23-month group, with a more complex vaccination schedule, is of concern. It is important to minimise errors in vaccination to achieve better protection rates.

Keywords:
Meningitis
Neisseria meningitidis
Serogroup B
Vaccination
Vaccines
Pediatrics
Medication errors
Resumen
Introducción

La enfermedad meningocócica provocada por Neisseria Meningitidis es una enfermedad potencialmente mortal, con las mayores tasas de incidencia en menores de 5 años. Desde 2015 se dispone en España de una vacuna contra el serogrupo B, el más predominante en Europa. El objetivo del estudio fue analizar la vacunación de Meningitis B a niños en Zaragoza.

Métodos

Se realizó un estudio observacional descriptivo con 11776 niños de 13 Centros de Salud del Sector I de Zaragoza, con edades de 0 meses a 15 años, con antecedente de vacunación de Meningitis B entre enero de 2015 y diciembre de 2019. Se determinó el sexo, fecha de nacimiento, fecha y edad de primovacunación, centro de salud y pauta vacunal. Se llevó a cabo un análisis descriptivo y contraste de hipótesis para analizar los resultados.

Resultados

El 50.4% de los vacunados tenía entre 2 y 9 años. En 2016, los menores de 3 meses representaban un 7.2% del total de vacunados, aumentando en 2019 a 50.9%. El 83.8% de los niños fueron bien vacunados, con edad media de 5.5 años. Los errores de intervalo fueron más comunes en el grupo de 12 a 23 meses (55.9%). No existían diferencias entre ambos sexos en relación a la pauta recibida.

Conclusiones

El porcentaje de bien vacunados es alto. Preocupa el porcentaje de errores de intervalo en el grupo de 12 a 23 meses, con una pauta de vacunación más compleja. Es importante minimizar los errores en la vacunación para conseguir mejores tasas de protección.

Palabras clave:
Meningitis
Neisseria meningitidis
Serogrupo B
Vacunación
Vacunas
Pediatria
Errores de Medicación

Article

These are the options to access the full texts of the publication Vacunas (English Edition)
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Vacunas (English Edition)

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Quizás le interese:
10.1016/j.vacune.2020.10.002
No mostrar más